SCHEMBL13876216

SCHEMBL13876216

CS(=O)(=O)c1ccc(CNC(=O)c2cccc(Oc3ncccn3)c2)c(Cl)c1

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 6/20 0.52
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
HPGD P15428 2/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 4/20 0.46
ALDH1A1 P00352 1/20 0.46
HSD17B10 Q99714 1/20 0.46
NR1H4 Q96RI1 2/20 0.45
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
RORC P51449 1/20 0.43
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
TSHR P16473 1/20 0.43
DDR1 Q08345 1/20 0.42
GCK P35557 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13876213 0.90 EPHX2 (0.56) EPHX2LMNANR1H4RORCROCK2
SCHEMBL13876172 0.86 TSHR (0.59) EPHX2MEN1KMT2AHPGDLMNA
SCHEMBL13876221 0.82 EPHX2 (0.56) EPHX2NR1H4MAPTRORCDDR1
SCHEMBL13876539 0.81 EPHX2 (0.67) EPHX2GAAALDH1A1HSD17B10NR1H4
SCHEMBL13876231 0.80 DDR1 (0.52) EPHX2MEN1KMT2AHPGDGAA
SCHEMBL13876802 0.80 EPHX2 (0.54) EPHX2NR1H4ROCK2ROCK1DDR1
SCHEMBL13876106 0.79 EPHX2 (0.53) EPHX2LMNAGAAALDH1A1HSD17B10
SCHEMBL4188160 0.77 EPHX2 (0.57) EPHX2LMNAGAAALDH1A1HSD17B10
SCHEMBL13876247 0.77 EPHX2 (0.64) EPHX2NR1H4RORCROCK2ROCK1
SCHEMBL4197572 0.76 EPHX2 (0.54) EPHX2NR1H4RORCROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 US disclosed
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-16 US disclosed
WO-2007098352-A2 SUBSTITUTED PYRIDINEAMIDE COMPOUNDS USEFUL AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-08-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090099184-A1 Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors EPHX1, EPHX2, NCEH1 EPHX2 2/4885MEN1 4518/4885KMT2A 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.